Back to GetFilings.com



Click Here for Index

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.

FOR THE QUARTER ENDED DECEMBER 31, 2003

COMMISSION FILE NO. 000–24969

mPhase Technologies, Inc.
(Exact name of registrant as specified in its charter)

NEW JERSEY 22-2287503
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
   
587 CONNECTICUT AVE., NORWALK, CT 06854-1711
(Address of principal executive offices) (Zip Code)

ISSUER’S TELEPHONE NUMBER, (203) 838–2741

INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934, DURING THE PRECEDING 12 MONTHS (OR FOR SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORT), AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS. YES  NO 

THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE REGISTRANT’S CLASSES OF COMMON STOCK AS OF FEBRUARY 9, 2004 IS 78,271,658 SHARES, ALL OF ONE CLASS OF $.01 STATED VALUE COMMON STOCK.

 


mPHASE TECHNOLOGIES, INC.
INDEX

      PAGE
PART I   FINANCIAL INFORMATION  
       
ITEM 1   FINANCIAL STATEMENTS  
       
      3
       
    4
         
    5
         
     
      6
     
      7
     
      8
     
ITEM 2     15
     
ITEM 3     26
     
ITEM 4   CONTROLS AND PROCEDURES   26
     
PART II   OTHER INFORMATION    
     
Item 1.   Legal Proceedings   27
     
Item 2.   Changes in Securities   27
     
Item 3.   Defaults Upon Senior Securities   27
     
Item 4.     27
       
Item 5.   Other Information   27
       
Item 6.   Exhibits on Reports on Form 8-K   28
       
Signature Page   29
       

2


Back to Index

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Balance Sheets
(Unaudited)

      June 30,     December 31,  
      2003     2003  




               
ASSETS              
CURRENT ASSETS              
Cash and cash equivalents   $ 396,860   $ 319,923  
Accounts receivable, net of bad debt reserve of $0 for each period
    287,135     182,136  
Stock subscription receivable     110,000     175,000  
Inventories, net     2,103,328     1,488,451  
Prepaid expenses and other current assets     100,329     69,911  




TOTAL CURRENT ASSETS     2,997,652     2,235,421  
       
Property and equipment, net     581,890     240,067  
Patents and licensing rights, net     184,857     129,924  
Other Assets     17,250     17,250  




TOTAL ASSETS     3,781,649     2,622,661  




LIABILITIES AND STOCKHOLDERS’ EQUITY              
               
CURRENT LIABILITIES              
Accounts payable     2,352,961     2,731,266  
Accrued expenses     885,735     430,016  
Due to related parties     187,372     584,902  
Notes payable, current     762,735     822,804  
Deferred revenue     214,180     214,180  
Notes payable, related parties         460,000  




TOTAL CURRENT LIABILITIES     4,402,983     5,243,169  




Long-term debt, net of current portion     586,303      
Other Liabilities     1,561,249     2,085,484  
Notes payable, related parties     460,000      




COMMITMENTS AND CONTINGENCIES (Note 9)              
STOCKHOLDERS’ DEFICIT              
Common stock, stated value $.01, 150,000,000 shares authorized; 71,453,521 and 74,861,525 shares issued and outstanding at June 30, 2003 and December 31, 2003, respectively
    714,535     748,615  
Additional paid in capital     104,081,049     105,135,240  
Deficit accumulated during development stage     (108,016,497 )   (110,581,874 )
Less-Treasury stock, 13,750 shares at cost     (7,973 )   (7,973 )




TOTAL STOCKHOLDERS’ DEFICIT     (3,228,886 )   (4,705,992 )




TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 3,781,649   $ 2,622,661  
 



 

The accompanying notes are an integral part of these financial statements.

3


Back to Index

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Operations
(Unaudited)

      Three Months Ended
December 31,
 
    October 2, 1996 (Date of Inception) to December 31,  
      2002     2003     2003  






REVENUES   $ 561,760   $ 1,290,935   $ 18,747,831  






COSTS AND EXPENSES                    
Cost of Sales     546,711     1,191,193     13,134,889  
Research and development                    
(including non-cash stock related charges of $43,750, $0 and $2,045,669, respectively)
    752,848     843,478     35,801,977  
General and Administrative                    
(including non-cash stock related charges of $258,058, $195,000 and $46,172,594 respectively)
    731,396     913,519     76,395,547  
Depreciation and amortization     128,652     27,978     2,841,111  






TOTAL COSTS AND EXPENSES     2,159,607     2,976,168     128,173,524  






LOSS FROM OPERATIONS     (1,597,847 )   (1,685,233 )   (109,425,693 )
                     
OTHER INCOME (EXPENSE)                    
Gain on extinguishments             226,549  
Minority interest loss in consolidated subsidiary             20,000  
Capital losses     (16,077 )       (1,466,467 )
Loss from unconsolidated subsidiary             (11,258 )
Interest Income (expense), net     (15,414 )   (15,633 )   74,995  






TOTAL OTHER INCOME (EXPENSE)     (31,491 )   (15,633 )   (1,156,181 )






NET LOSS   $ (1,629,338 ) $ (1,700,866 ) $ (110,581,874 )






LOSS PER COMMON SHARE, basic and diluted   $ (.03 ) $ (.02 )      




WEIGHTED AVERAGE COMMON                    
SHARES OUTSTANDING, basic and diluted     65,914,466     72,814,272        




The accompanying notes are an integral part of these consolidated financial statements.

4


Back to Index

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Operations
(Unaudited)

      Six Months Ended
December 31,
 
    October 2, 1996 (Date of Inception) to December 31,  
      2002     2003     2003  






REVENUES   $ 771,837   $ 3,780,137   $ 18,747,831  






COSTS AND EXPENSES                    
Cost of Sales     744,030     3,289,937     13,134,889  
Research and development                    
including non-cash stock related charges of $262,500, $0 and $2,045,669, respectively)
    1,556,142     1,454,899     35,801,977  
General and Administrative                    
(including non-cash stock related charges of $484,358, $307,245 and $46,172,894, respectively)
    1,624,178     1,518,411     76,395,547  
Depreciation and amortization     259,381     74,082     2,841,111  






TOTAL COSTS AND EXPENSES     4,183,731     6,337,329     128,173,524  






LOSS FROM OPERATIONS     (3,411,894 )   (2,557,192 )   (109,425,693 )
                     
OTHER INCOME (EXPENSE)                    
Gain on extinguishments     40,724     23,087     226,549  
Minority interest loss in consolidated subsidiary             20,000  
Capital losses     (16,077 )       (1,466,467 )
Loss from unconsolidated subsidiary             (11,258 )
Interest Income (expense), net     (34,149 )   (31,272 )   74,995  






TOTAL OTHER INCOME (EXPENSE)     (9,502 )   (8,185 )   (1,156,181 )






NET LOSS   $ (3,421,396 ) $ (2,565,377 ) $ (110,581,874 )






                     
LOSS PER COMMON SHARE, basic and diluted   $ (.06 ) $ (.04 )      




WEIGHTED AVERAGE COMMON                    
SHARES OUTSTANDING, basic and diluted     63,397,799     72,251,251        




The accompanying notes are an integral part of these consolidated financial statements.

5


Back to Index

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statement of Changes in Shareholders’ Deficit
(Unaudited)

     Shares    $.01 Stated Value    Treasury Stock    Additional
Paid-in
Capital
   Accumulated Deficit    Total Shareholders (Deficit) Equity  












Balance June 30, 2003
    71,453,521   $ 714,535   $ (7,973 ) $ 104,081,049   $ (108,016,497 ) $ (3,228,886 )












Issuance of common stock with warrants in private placements
    1,983,337     19,834         611,194         631,028  
Issuance of common stock for services
     924,667     9,246          238,154         247,400  
Issuance of common stock pursuant to exercise of warrants
    500,000     5,000         145,000         150,000  
Issuance of warrants to purchase common stock for services
                59,843          59,843  
Net loss                     (2,565,377 )   (2,565,377 )












Balance, December 31, 2003
    74,861,525   $ 748,615   $ (7,973 ) $ 105,135,240   $ (110,581,874 ) $ (4,705,992 )












 

The accompanying notes are an integral part of these consolidated financial statements.

6


Back to Index

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Cash Flows
(Unaudited)

      Six Months Ended
December 31,
 
    October 2, 1996 (Date of Inception) to December 31,  
      2002     2003     2003  






Cash Flow From Operating Activities:                    
Net Loss   $ (3,421,396 ) $ (2,565,377 ) $ (110,581,874 )
Adjustments to reconcile net loss to net cash used in operating activities:
                   
Depreciation and amortization     753,433     402,257     5,996,397  
Book Value of fixed assets disposed     16,077         74,272  
Provision for doubtful accounts              32,124  
Gain on debt extinguishments     (40,725 )   (23,087 )   (226,549 )
Loss on unconsolidated subsidiary             1,466,467  
Impairment of note receivable             232,750  
Loss on securities             11,258  
Non-cash charges relating to issuance of common stock, common stock options and Warrants
    790,608     307,245     48,451,342  
Changes in assets and liabilities:                    
Accounts receivable     (68,859 )   104,999     (214,260 )
Inventories     630,237     614,876     (1,278,212 )
Prepaid expenses and other current assets     69,324     30,418     (566,203 )
Other non-current assets     2,695          
Accounts payable         401,394     4,558,788  
Accrued expenses     (15,229 )   (419,559 )   1,393,184  
Due to/from related parties                    
   Microphase     495,566     313,226     2,609,175  
   Janifast     107,204     534,887     2,814,888  
   Officers     60,048     (450,583 )   108,756  
   Lintel             477,000  
   Others             211,972  
Receivables from Subsidiary             (150,000 )
Deferred revenue             214,180  






Net cash used in operating activities
    (621,017 )   (749,304 )   (44,364,545 )






Cash Flow from Investing Activities:                    
Payments related to patents and licensing rights             (375,720 )
Purchase of fixed assets         (5,500 )   (2,542,605 )






Net Cash (used)/provided by investing activities         (5,500 )   (2,918,325 )






Cash Flow from Financing Activities:                    
Proceeds from issuance of common stock and exercises of options and warrants
        679,867     47,187,785  
Payments of notes payable     (39,425 )   (2,000 )   (204,859 )
Advances from related party     623,290         627,840  
Repurchase of treasury stock at cost             (7,973 )






Net cash provided by financing activities
    583,865     677,867     47,602,793  






Net increase (decrease) in cash     (37,152 )   (76,937 )   319,923  
CASH AND CASH EQUIVALENTS, beginning of period
    47,065     396,860      






CASH AND CASH EQUIVALENTS, end of period
  $ 9,913   $ 319,923   $ 319,923  






The accompanying notes are an integral part of these consolidated financial statements.

7


Back to Index

mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

1.     BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF OPERATIONS
 
mPhase Technologies, Inc. (the “Company”) was organized on October 2, 1996. On February 17, 1997, the Company acquired Tecma Laboratories, Inc. (“Tecma”) in a transaction accounted for as a reverse merger. On June 25, 1998, the Company acquired Microphase Telecommunications, Inc. (“MicroTel”), through the issuance of 2,500,000 shares of its common stock in exchange for all the issued and outstanding shares of MicroTel. The assets acquired in this acquisition were patents related to the mPhase line of DSL component products (e.g., POTS Splitters) and patent applications utilized in the Company’s proprietary Traverser™ Digital Video Data Delivery System (“Traverser”). The primary business of the company is to design, develop, manufacture and market high band-width telecommunication products incorporating digital subscriber line (“DSL”) technology. The present activities of the Company are focused (a) upon cost reduction and enhancement of its proprietary Traverser™ product under an Agreement with Lucent Technologies, Inc. and (b) deployment of the Traverser™ product. The Traverser™ enables telecommunications service providers to simultaneously deliver MPEG2 digital quality television (utilizing non-internet protocol), high-speed Internet and voice over copper telephone wire utilizing DSL technology. Additionally, the Company sells DSL component products which includes microfilters, splitters, and line extenders.
 
The Company is in the development stage, as defined by Statement of Financial Accounting Standards (“SFAS”) No. 7, “Accounting and Reporting by Development Stage Enterprises.” and its present activities are focused on the commercial deployment of its proprietary Traverser™ and associated DSL component products. Since mPhase is in the development stage, the accompanying consolidated financial statements should not be regarded as typical for normal operating periods.
 
BASIS OF PRESENTATION – The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and pursuant to the regulations of the Securities Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ending December 31, 2003 are not necessarily indicative of the results that may be expected for a full fiscal year. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2003.
 
Through December 31, 2003, the Company had incurred cumulative (a) development stage losses totaling approximately $110,581,874 and (b) negative cash flow from operations equal to $44,364,545. At December 31, 2003, the Company had approximately $319,923 of cash, cash equivalents and approximately $182,136 of trade receivables to fund short-term working capital requirements. The Company’s ability to continue as a going concern and its future success is dependent upon its ability to raise capital in the near term to: (1) satisfy its current obligations, (2) continue its research and development efforts, and (3) allow the successful wide scale development, deployment and marketing of its products.
 
USE OF ESTIMATES – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

8


Back to Index

mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

RECLASSIFICATIONS – Certain reclassifications have been made in the prior period consolidated financial statements to conform to the current period presentation.
 
LOSS PER COMMON SHARE, BASIC AND DILUTED – The Company accounts for net loss per common share in accordance with the provisions of SFAS No. 128, “EARNINGS PER SHARE” (“EPS”). SFAS No. 128 requires the disclosure of the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity. Common equivalent shares have been excluded from the computation of diluted EPS for all periods presented since their affect is antidilutive.
 
RESEARCH AND DEVELOPMENT – Research and development costs are charged to operations as incurred.
 
REVENUE RECOGNITION – All revenue included in the accompanying consolidated statements of operations for all periods presented relates to sales of mPhase’s line of POTS Splitter products and other related DSL component products. As required, the Company adopted the Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 101, REVENUE RECOGNITION IN FINANCIAL STATEMENTS, which provides guidance on applying generally accepted accounting principles to revenue recognition based on the interpretations and practices of the SEC. The Company recognizes revenue for its line of POTS Splitter products and other DSL component products at the time of shipment, at which time, no other significant obligations of the Company exist, other than normal warranty support. In addition, the Company includes costs of shipping and handling billed to customers in revenue and the related expenses of shipping and handling costs is included in cost of sales.
 
STOCK-BASED COMPENSATION – During the second quarter of fiscal 2004, the Company adopted the fair value recognition provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation, for stock-based employee compensation, effective as of the beginning of the fiscal year. Under the modified prospective method of adoption selected by the Company, stock-based employee compensation cost recognized in 2003 is the same as that which would have been recognized had the fair value recognition provisions of Statement 123 been applied to all awards granted after October 1, 1995. The following table illustrates the effect on net income and earnings per share as if the fair value based method has been applied to all outstanding and unvested awards in each period.
               
    Three Months Ended
December 31,
  Six Months Ended
December 31,
 










    2003   2002   2003   2002  








Net loss, as reported   $ (1,700,866 ) $ (1,629,338 ) $ (2,565,377 ) $ (3,421,396 )
Add: Stock-based employee compensation expense included in reported net income, net of related tax effects         1,403         23,923  
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects         (12,016 )       (204,885 )








Pro forma net loss   $ (1,700,866 ) $ (1,639,951 ) $ (2,565,337 ) $ (3,602,358 )








Loss per share:                          
     Basic and diluted—as reported   $ (.02 ) $ (.03 ) $ (.04 ) $ (.06 )
     Basic and diluted—pro forma   $ (.02 ) $ (.03 ) $ (.04 ) $ (.06 )